News
NAII
1.700
-2.86%
-0.050
Natural Alternatives GAAP EPS of -$2.23, revenue of $34.5M
Seeking Alpha · 6h ago
Natural Alternatives International Says Initiated A Comprehensive Review Process To Explore Strategic Alternatives; Initiated Consolidation Of Our USA Manufacturing Operations Into Our Vista, CA Facility
Benzinga · 6h ago
Press Release: Natural Alternatives -2-
Dow Jones · 6h ago
*Natural Alternatives 4Q Loss $13.5M >NAII
Dow Jones · 6h ago
*Natural Alternatives 4Q Sales $34.5M >NAII
Dow Jones · 6h ago
*Natural Alternatives 4Q Loss/Shr $2.23 >NAII
Dow Jones · 6h ago
Weekly Report: what happened at NAII last week (0921-0925)?
Weekly Report · 16h ago
Weekly Report: what happened at NAII last week (0914-0918)?
Weekly Report · 09/21 09:57
Weekly Report: what happened at NAII last week (0907-0911)?
Weekly Report · 09/14 10:00
Weekly Report: what happened at NAII last week (0831-0904)?
Weekly Report · 09/07 09:56
Weekly Report: what happened at NAII last week (0824-0828)?
Weekly Report · 08/31 10:01
Weekly Report: what happened at NAII last week (0817-0821)?
Weekly Report · 08/24 10:01
Weekly Report: what happened at NAII last week (0810-0814)?
Weekly Report · 08/17 10:02
Weekly Report: what happened at NAII last week (0803-0807)?
Weekly Report · 08/10 09:58
3 Microcaps for Your Watchlist
NASDAQ · 08/06 07:57
Weekly Report: what happened at NAII last week (0727-0731)?
Weekly Report · 08/03 09:58
Weekly Report: what happened at NAII last week (0720-0724)?
Weekly Report · 07/27 10:01
Weekly Report: what happened at NAII last week (0713-0717)?
Weekly Report · 07/20 09:58
Top 3 Risk Off Stocks That May Rocket Higher In Q3
Benzinga · 07/15 10:22
Weekly Report: what happened at NAII last week (0706-0710)?
Weekly Report · 07/13 10:00
More
Webull provides a variety of real-time NAII stock news. You can receive the latest news about Naturl Alt Intl through multiple platforms. This information may help you make smarter investment decisions.
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.